Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Applying to The Oncology Institute of Hope and Innovation · Cerritos, California
Answer a few short questions to share with the research team.